- Report
- April 2025
- 50 Pages
Global
From €2503EUR$2,650USD£2,129GBP
Olaquindox is a broad-spectrum antibiotic used in animal pharmaceuticals. It is used to treat a variety of bacterial infections in livestock, including swine dysentery, colibacillosis, and salmonellosis. Olaquindox is also used to prevent and treat coccidiosis in poultry. It is available in a variety of formulations, including tablets, capsules, and injectable solutions.
The Olaquindox market is highly competitive, with a number of companies offering products for animal pharmaceuticals. These companies include major multinationals such as Bayer, Merck, and Zoetis, as well as smaller regional players such as Huvepharma, Huvepharma Animal Health, and Huvepharma Animal Nutrition. Additionally, there are a number of generic manufacturers offering Olaquindox products at lower prices. Show Less Read more